News
NEEDHAM, MA / ACCESS Newswire / June 10, 2025 / ECM PCB Stator Tech has announced PrintStator v8.3, a major update to its ...
Factory Wonders on MSN3d
How Electric Motors Convert Power: Three-Phase AC Induction Motor ExplainedIn this detailed video, we break down the working principles of one of the most widely used electric motors in industrial ...
Alumis Inc. has announced the successful completion of patient enrollment in its pivotal Phase 3 ONWARD clinical program for ESK-001, a treatment for moderate-to-severe plaque psoriasis ...
delivering multi-phase, high-current power switching modules, motor control systems and software, across a wide range of power requirements.” The unit measures 104 x 154 x 34mm and 550g. On resistance ...
Copyright: © 2025 The Author(s). Published by Elsevier Ltd.
Abstract: In this article, a novel predictive torque and stator flux control (PTSF) method is proposed for N-segment three-phase permanent magnet synchronous motor (N*3-phase PMSM), which can ...
Presentation to include positive clinical results from the Phase 3 SURPASS-ET clinical trial of ropeginterferon alfa-2b-njft for the treatment of essential thrombocythemia (ET) PharmaEssentia USA ...
Then, the six-segment three-phase PMSM predictive control system driven by six parallel inverters is designed to generate the required torque. Furthermore, the influence of the parameter mismatch on ...
The company's phase 3 Essence study tested the therapy in patients with moderate hypertriglyceridemia who have or are at risk for atherosclerotic cardiovascular disease (ASCVD ...
During the 48-week double-blind treatment period, 6 patients (7.4%) in the molgramostim group underwent a total of 15 WLLs and 11 patients (13.3%) in the placebo group underwent a total of 24 WLLs ...
cDivision of Endocrinology, Metabolism & Lipid Research, Washington University School of Medicine, St Louis, MO, USA dDivision of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD ...
BioMarin has followed through on its shift to external innovation, inking a deal to buy Inozyme for $270 million to add a phase 3 enzyme replacement therapy to its pipeline. California-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results